The Impact of Respiratory Strength Training in Individuals With Amyotrophic Lateral Sclerosis (ALS)

Study Purpose:

Dysphagia (swallow impairment), dystussia (cough impairment) and respiratory impairment are hallmark features of amyotrophic lateral sclerosis (ALS). These symptoms are the cause of fatal aspiration, malnutrition and respiratory insufficiency that together account for 91.4% of ALS mortality. Unfortunately, treatments to prolong and maintain these vital functions are currently lacking. Although the use of exercise in ALS is controversial, recent evidence suggests that mild to moderate intensity exercise applied early in the disease slows disease progression, improves motor function, preserves motor neuron number, reduces muscle hypoplasia, atrophy astrogliosis, and prolongs survival in animal models of ALS and human clinical trials.

This research study is designed to determine the impact of respiratory strength training on breathing, airway protection and swallowing in persons with Amyotrophic Lateral Sclerosis (ALS).

Disease:

Amyotrophic Lateral Sclerosis (ALS),  Familial ALS,  Sporadic ALS

Study Type:

Interventional Trial

Study Category:

Device

Study Status:

Active, currently recruiting

Phase:

Phase 0

Study Chair(s)/Principal Investigator(s):

Emily K Plowman, Ph.D. University of Florida

Clinicaltrials.gov ID (11 digit #):

NCT02710110

Neals Affiliated?

No

Coordinating Center Contact Information

UF Health Shands
Lauren Tabor, M.S.; Raele Robison, M.S. / .(JavaScript must be enabled to view this email address) / 443-536-1234; 610-504-4605
.(JavaScript must be enabled to view this email address) Gainesville, Florida 32605 United States

Full Study Summary:

This research study will measure the maximum inspiratory and expiratory pressure with secondary measures of respiration, swallow, cough, quality of life and global disease progression following twelve-weeks of treatment compared to the sham group.

As a participant two evaluations at the University of Florida Swallowing Systems Core laboratory located at Shands Hospital, Gainesville will take place. Each will take approximately two-hours and these will be spaced exactly three-months apart. During each evaluation tests will be performed to look at breathing, swallowing, and ability to cough doing standard clinical exams. In addition, some surveys about eating, speaking and quality of life will be taken.

Breathing Exercises: a home research therapist will train the participants how to use the hand-held respiratory trainer. Training for both treatment groups will be very similar, except the PowerLung trainer device will have an additional spring load valve inside it that will place a force on the respiratory muscles during training. The other breathing trainer will not have this spring so that no resistance will be placed on the respiratory muscles during training and this will represent an aerobic respiratory treatment. The breathing exercises will be completed five days a week for a total of three months (a total of 60 therapy sessions). During each session, a total of three sets of ten repetitions of breathing exercises will be performed. Once a week the home research therapist will visit and guide participants through the breathing exercise.

Study Sponsor:

University of Florida and The ALS Association

Participant Duration:

Estimated Enrollment:

50

Estimated Study Start Date:

04/01/2016

Estimated Study Completion Date:

03/01/2019

Posting Last Modified Date:

11/29/2016

Date Study Added to alsconsortium.org:

11/29/2016
  • Eligibility Criteria

    Gender:

    Female, Male

    Minimum Age:

    21

    Maximum Age:

    85

    Min Vital Capacity (% predicted normal):

    70

    Time since Symptom Onset:

    Time since Diagnosis:

    Can participants use Riluzole?


    Inclusion Criteria:
    diagnosis of probable or definite Amyotrophic Lateral Sclerosis (ALS),
    Amyotrophic Lateral Sclerosis Rating Scale Revised score greater than 34,
    forced vital capacity greater than 70%,
    cognition within normal limits as determined by Montreal assessment of cognition score >25

    Exclusion Criteria:
    allergies to barium,
    tracheotomy or mechanical ventilation,
    diaphragmatic pacer,
    concurrent respiratory disease (e.g. COPD),
    pregnant at the time of the study due to radiation exposure

  • Site Contact Information

    UF Health Shands
    Gainesville, Florida 32605
    United States